A comprehensive view of Licensing/Royalty. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Harrow closes acquisition of US rights to five branded Novartis ophthalmic drugs; Harrow paid US$130.0M at closing, with an additional milestone payment due upon the commercial availability of Triesence
Published: January 24, 2023 by Ophthalmology Times
Hindustan Unilever approves proposal to raise royalty payout to parent company Unilever for the provision of technology, trademark licenses and services to HUL; royalty and central services fees will increase to 3.45% from 2.65% over three years
Published: January 19, 2023 by Mint (New Delhi)
SustainaPac becomes new licensee of PulPac's Dry Molded Fiber technology, intends to build a series of single-use foodservice packaging facilities across the US, beginning with a high-volume fiber hot and cold drink cup lid plant in Jacksonville, Florida
Published: January 17, 2023 by PulPac AB
Mohawk Industries enters into agreement to settle securities class action lawsuit filed on Jan. 3, 2020, for US$60M; company has also settled a dispute with Belgian Tax Authority regarding tax treatment of royalty income for €3M
Published: January 16, 2023 by Mohawk Industries Inc.
Dr. Reddy's acquires trademark rights from Pfizer for Primcyv breast cancer drug as an oral capsule in India; Dr. Reddy's to manufacture Primcyv’s active pharmaceutical ingredient and finished drug at its FDA-approved state-of-the-art facilities
Published: January 16, 2023 by BioSpectrum India

Ask us about our Chemicals Industry market view

Trending Chart

Interactive chart with headline count